Skip to content
HowShorted

Akoustis Technologies, Inc. short interest in 2022

In 2022, Akoustis Technologies, Inc.'s disclosed short interest ran from 9.28% of shares outstanding on 14 Jan 2022 to 8.60% on 30 Dec 2022, a change of -0.68 percentage points. The year's high was 10.68% on 15 Feb 2022 and its low 7.78% on 15 Dec 2022, averaging 9.55% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.32 days on 15 Jul 2022. Full history: Akoustis Technologies, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Akoustis Technologies, Inc. in 2022

2022 in figures

Start of year
9.28% (14 Jan 2022)
End of year
8.60% (30 Dec 2022)
Change
-0.68 pp
High
10.68% (15 Feb 2022)
Low
7.78% (15 Dec 2022)
Average
9.55%
Highest days to cover
25.32 (15 Jul 2022)
SEC filings marked
8

Every report in 2022

Akoustis Technologies, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20229.28%8.62
31 Jan 202210.20%6.0110-Q filed, results (8-K)
15 Feb 202210.68%7.77
28 Feb 202210.50%8.77
15 Mar 202210.40%15.14
31 Mar 202210.15%10.43
14 Apr 20229.72%13.89
29 Apr 202210.15%9.55
13 May 202210.08%7.3510-Q filed, results (8-K)
31 May 202210.24%10.89
15 Jun 202210.49%12.24
30 Jun 202210.46%10.06
15 Jul 202210.66%25.32
29 Jul 202210.27%20.84
15 Aug 20229.39%17.66
31 Aug 20229.42%22.42
15 Sep 20229.24%13.9410-K filed, results (8-K)
30 Sep 20228.83%10.93
14 Oct 20228.59%8.03
31 Oct 20228.27%9.12
15 Nov 20227.92%12.1410-Q filed, results (8-K)
30 Nov 20227.84%14.23
15 Dec 20227.78%19.10
30 Dec 20228.60%9.46

See also: Akoustis Technologies, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.